NOT

Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering of $30 Million

Retrieved on: 
Tuesday, March 12, 2024

VICTORIA, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company, today announced that it has priced its previously announced overnight marketed public offering (the “Offering”) of common shares of the Company (the “Shares”). Pursuant to the Offering, Eupraxia will issue 7,317,000 Shares at a price of C$4.10 per Share for gross proceeds of C$30 million.

Key Points: 
  • Pursuant to the Offering, Eupraxia will issue 7,317,000 Shares at a price of C$4.10 per Share for gross proceeds of C$30 million.
  • The Offering is being conducted pursuant to the terms and conditions of an underwriting agreement between the Company and Raymond James Ltd. as sole underwriter and bookrunner (the “Underwriting Agreement”).
  • Closing of the Offering is subject to a number of customary conditions, including approval of the Toronto Stock Exchange.
  • The Offering will be made in Canada only by means of the base shelf prospectus and prospectus supplement.

Abcourt Announces a Non-Brokered Private Placement for up to $5.0 Million Resulting in the Creation of a Control Person

Retrieved on: 
Tuesday, March 12, 2024

ROUYN-NORANDA, Quebec, March 12, 2024 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) is pleased to announce a non-brokered private placement of up to 100,000,000 units of the Corporation (“Units”) at a price of $0.05 per Unit for aggregate gross proceeds of up to $5,000,000 (the “Private Placement”) as a result of which François Mestrallet, a director of the Corporation, will become a Control Person of the Corporation (as such term is defined in the policies of the TSX Venture Exchange (the “TSXV”).

Key Points: 
  • Each Unit will consist of one common share of the Corporation (a “Common Share”) and one common share purchase warrant (a “Warrant”).
  • The Private Placement is expected to close on or about March 26, 2024 and remains subject to approval of the TSXV.
  • Shareholders of the Corporation will be asked at the Special Meeting to consider and, if thought fit, to pass a resolution (the “Control Person Resolution”) approving the creation of a Control Person.
  • Additional information regarding the Private Placement and the Control Person Resolution will be provided in the management information circular to be prepared in respect of the Special Meeting.

SilverBow Resources Highlights Successful Implementation of Strategy and Positive Business Momentum

Retrieved on: 
Thursday, March 28, 2024

SilverBow has been successfully implementing our strategy of building a scalable and durable portfolio, driving efficiencies and enhancing margins, protecting the balance sheet, and delivering profitable growth.

Key Points: 
  • SilverBow has been successfully implementing our strategy of building a scalable and durable portfolio, driving efficiencies and enhancing margins, protecting the balance sheet, and delivering profitable growth.
  • From 2020 to 2023, we have more than doubled our portfolio to approximately 1,000 gross locations across 220,000 acres.
  • Our strategy has proven to be resilient through market cycles and has delivered significant shareholder value, with total shareholder returns of more than 550% since 2021.
  • Our results are telling a clear story of the positive momentum in our business.

Galderma Announces Full Exercise of Over-Allotment Option

Retrieved on: 
Tuesday, March 26, 2024

Galderma Group AG (the “Company” or “Galderma”), the pure-play dermatology category leader, today announces that the Joint Global Coordinators exercised in full their option to purchase an additional 5,626,592 shares from Sunshine SwissCo AG (EQT), a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte.

Key Points: 
  • Galderma Group AG (the “Company” or “Galderma”), the pure-play dermatology category leader, today announces that the Joint Global Coordinators exercised in full their option to purchase an additional 5,626,592 shares from Sunshine SwissCo AG (EQT), a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte.
  • Including the shares placed in connection with the over-allotment option, a total of 43,137,209 existing registered and newly issued registered shares have been sold in the IPO.
  • Following the full exercise of the over-allotment option, the free float as calculated by SIX is expected to increase from 20.4% to 22.8%.
  • Goldman Sachs International, Morgan Stanley and UBS acted as Joint Global Coordinators and Joint Bookrunners for the IPO.

Galderma Prices IPO at CHF 53 Per Share and Will Start Trading on the SIX Swiss Exchange Tomorrow

Retrieved on: 
Thursday, March 21, 2024

THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN.

Key Points: 
  • THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN.
  • Galderma Group AG, the pure-play dermatology category leader, today announces the pricing of its Initial Public Offering at CHF 53 per share, at the top of the announced price range.
  • The shares will be listed and start trading under the ticker symbol “GALD” on the SIX Swiss Exchange tomorrow, March 22, 2024.
  • To access the full announcement on the public offering of securities of Galderma Group AG in Switzerland, for those legally permitted, please visit www.galderma.com/intentiontofloat .

Galderma Launches IPO on the SIX Swiss Exchange and Sets Price Range

Retrieved on: 
Wednesday, March 13, 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Key Points: 
  • NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
  • THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN.
  • Galderma Group AG, the pure-play dermatology category leader, today announces the publication of its prospectus and the start of the book-building process, as part of its intention to conduct an Initial Public Offering on the SIX Swiss Exchange.
  • To access the full announcement, please visit www.galderma.com/intentiontofloat .

Aquaporin publishes prospectus and initiates rights issue

Retrieved on: 
Friday, April 5, 2024

COPENHAGEN, Denmark, April 5, 2024 /PRNewswire/ -- Aquaporin A/S ("Aquaporin" or the "Company") (CSE: AQP) today announces that its board of directors (the "Board of Directors") has resolved to initiate a rights issue with pre-emptive subscription rights (the "Pre-emptive Rights") for the Company's existing shareholders allowing for subscription of up to 14,594,872 new shares with a nominal value of DKK 1 each (the "New Shares") at a subscription price of DKK 14 per New Share (the "Subscription Price") (the "Offering" or the "Rights Issue").

Key Points: 
  • : DK28315694
    COPENHAGEN, Denmark, April 5, 2024 /PRNewswire/ -- Aquaporin A/S ("Aquaporin" or the "Company") (CSE: AQP) today announces that its board of directors (the "Board of Directors") has resolved to initiate a rights issue with pre-emptive subscription rights (the "Pre-emptive Rights") for the Company's existing shareholders allowing for subscription of up to 14,594,872 new shares with a nominal value of DKK 1 each (the "New Shares") at a subscription price of DKK 14 per New Share (the "Subscription Price") (the "Offering" or the "Rights Issue").
  • A prospectus regarding the Offering (the "Prospectus") is, subject to certain restrictions, available at the Company's website: https://investors.aquaporin.com/investors/default.aspx .
  • Trades of Pre-emptive Rights executed during the Rights Trading Period will, however, not be affected.
  • Consequently, investors who have acquired Pre-emptive Rights will incur a loss corresponding to the purchase price of the Pre-emptive Rights and any transaction costs.

MARCH HARVARD CAPS / HARRIS POLL: TRUMP'S LEAD NARROWS TO 2 POINTS AFTER BIDEN GIVES STATE OF THE UNION

Retrieved on: 
Monday, March 25, 2024

NEW YORK and CAMBRIDGE, Mass., March 25, 2024 /PRNewswire/ -- Stagwell (NASDAQ: STGW) today released the results of the March Harvard CAPS / Harris poll, a monthly collaboration between the Center for American Political Studies at Harvard (CAPS) and the Harris Poll and HarrisX.

Key Points: 
  • President Joe Biden's overall approval rating remained at 45%, while 55% of voters say they approve of Donald Trump's job as president.
  • Trump is leading Biden by 2 points in the general head-to-head, down from 6 points last month.
  • The March Harvard CAPS / Harris poll survey was conducted online within the United States on March 20-21, 2024, among 2,111 registered voters by The Harris Poll and HarrisX.
  • Follow the Harvard CAPS Harris Poll podcast at https://www.markpennpolls.com/ or on iHeart Radio, Apple Podcasts, Spotify, and other podcast platforms.

SURVEY: OVER HALF OF RECENT CANADIAN IMMIGRANTS REPORT TO 'LESS QUALIFIED' CAUCASIAN MANAGERS

Retrieved on: 
Monday, March 18, 2024

51.40% of recent and employed immigrants say they report to a manager who is LESS QUALIFIED but Caucasian.

Key Points: 
  • 51.40% of recent and employed immigrants say they report to a manager who is LESS QUALIFIED but Caucasian.
  • 50.8% say they report to a manager who is LESS QUALIFIED but second or third-generation Canadian.
  • A combined total of 60.8% of immigrants have experienced microaggressions or subtle forms of discrimination in the workplace.
  • Over half of immigrants (50.8%) say they have 'looked the other way' when a recent immigrant colleague experienced racism in the workplace.

LIFT ANNOUNCES MARKETED PUBLIC OFFERING

Retrieved on: 
Monday, March 18, 2024

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Key Points: 
  • /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
    VANCOUVER, BC, March 18, 2024 /CNW/ - Li-FT Power Ltd. ("LIFT" or the "Company") (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to announce that it has commenced a marketed best efforts public offering (the "Public Offering") of up to 1,179,500 common shares of the Company that will qualify as "flow-through shares" (within the meaning of subsection 66(15) of the Income Tax Act (Canada)) (the "Flow-Through Shares") at a price of $6.05 per Flow-Through Share (the "Offering Price") for aggregate gross proceeds of up to $7,135,975.
  • The Public Offering is being conducted through a syndicate of agents led by Canaccord Genuity Corp. (collectively, the "Agents").
  • The Public Offering will be conducted pursuant to the Company's Canadian base shelf prospectus dated December 22, 2023 (the "Base Shelf Prospectus").
  • The Public Offering and the Non-Brokered Offering are subject to the satisfaction of certain conditions, including receipt of all applicable regulatory approvals including the approval of the TSX Venture Exchange.